NVS
Novartis AG
Stock
$141.00−0.05 (−0.04%)Close Oct 2, 2026
- Operating cash flow, 2025
- $19.1B
- YoY, 2025
- +8.7%
- 5-year CAGR
- +7.0%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $19.1B | +8.7% |
| 2024 | $17.6B | +21.9% |
| 2023 | $14.5B | +1.6% |
| 2022 | $14.2B | −5.5% |
| 2021 | $15.1B | +10.4% |
| 2020 | $13.7B | +0.2% |
| 2019 | $13.6B | −4.5% |
| 2018 | $14.3B | +13.1% |
| 2017 | $12.6B | +10.0% |
| 2016 | $11.5B | — |